Marker Therapeutics Inc.
MRKR | NASDAQ
$1.21
+$0.01 (+0.83%)
Sep 22, 2026, 11:09 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 1.23M | 861.18K | 349.1K | 2.25M | 1.93M | 1.17M | 1.24M | 1.06M | 257.61K | 762.66K | 1.23M | 759.14K | 999.57K | 790.51K | 964.32K | 1.24M | n/a | n/a | n/a |
Cost of Revenue | n/a | 2.84M | n/a | 2.35M | 4.18M | 3.14M | 5.09M | 3.47M | 2.34M | 2.58M | 2.62M | 2.04M | 2.38M | 3.38M | 2.18M | 3.59M | 2.92M | 834.22K | 820.19K | 805.25K | 782.83K | 754.37K |
Gross Profit | n/a | -2.84M | n/a | -1.11M | -3.32M | -2.79M | -2.83M | -1.55M | -1.17M | -1.33M | -1.56M | -1.79M | -1.62M | -2.14M | -1.42M | -2.59M | -2.13M | 130.1K | 421.53K | -805.25K | -782.83K | -754.37K |
Operating Income | -2.62M | -4.07M | -1.88M | -2.14M | -4.26M | -4.61M | -3.86M | -2.4M | -2.31M | -2.55M | -2.94M | -3.2M | -4.13M | -4.31M | -3.04M | -5.83M | -5.27M | -9.79M | -9.76M | -10.02M | -10.91M | -8.78M |
Interest Income | 112.56K | 132.89K | 165.63K | 138.06K | 128.03K | 162.49K | 73.75K | 91.68K | 115.39K | 156.2K | 201.34K | 218.09K | 35.08K | 84.65K | 109.41K | 99.75K | 35.79K | 3.12K | 969 | 791 | 2.4K | 1.54K |
Pretax Income | -1.83M | -3.18M | -1.72M | -2M | -4.02M | -4.45M | -3.79M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -4.1M | -4.22M | -3.04M | -5.73M | -5.23M | -9.91M | -9.76M | -12.43M | -10.91M | -8.78M |
Net Income | -1.83M | -3.18M | -1.7M | -2M | -4.02M | -4.45M | -3.84M | -2.31M | -2.19M | -2.39M | -2.8M | -2.98M | 2.52M | -4.97M | -3.86M | -6.92M | -9.24M | -9.91M | -9.76M | -12.43M | -10.91M | -8.78M |
Selling & General & Admin | 1.14M | 1.23M | 846.61K | 1.02M | 945.16K | 1.37M | 1.03M | 854.68K | 1.14M | 1.22M | 1.38M | 1.41M | 2.52M | 2.17M | 1.62M | 3.23M | 3.14M | 2.9M | 2.17M | 2.43M | 2.78M | 2.38M |
Research & Development | 1.48M | 2.84M | 2.14M | 2.35M | 4.18M | 3.14M | 5.09M | 3.47M | 2.34M | 2.58M | 2.62M | 2.04M | 2.38M | 3.38M | 2.18M | 3.59M | 2.92M | 7.03M | 8.02M | 6.78M | 7.35M | 5.64M |
Other Expenses | n/a | -2.84M | -1.1M | -2.35M | -4.18M | -2.68M | -5.09M | -3.47M | -2.34M | -2.58M | -2.62M | -2.04M | -2.38M | -3.38M | -2.18M | -3.59M | -2.92M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.62M | 1.23M | 1.88M | 1.02M | 945.16K | 1.82M | 1.03M | 854.68K | 1.14M | 1.22M | 1.38M | 1.41M | 2.52M | 2.17M | 1.62M | 3.23M | 3.14M | 9.92M | 10.19M | 9.22M | 10.13M | 8.03M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 4.07M | 1.88M | 3.37M | 5.12M | 4.96M | 6.11M | 4.33M | 3.48M | 3.79M | 3.99M | 3.46M | 4.9M | 5.54M | 3.8M | 6.83M | 6.06M | 10.76M | 11.01M | 10.02M | 10.91M | 8.78M |
Income Tax Expense | n/a | n/a | -15.16K | n/a | n/a | n/a | 49.95K | n/a | n/a | n/a | 3.68K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.31M | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.17M | 8.29M | 8.3M | 5.65M |
Shares Outstanding (Diluted) | 19.31M | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.32M | 8.31M | 8.3M | 5.65M |
EPS (Basic) | -0.09 | -0.16 | -0.10 | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 | -0.25 | -0.27 | -0.31 | -0.34 | 0.29 | -0.57 | -0.48 | -0.83 | -1.11 | -1.19 | -1.19 | -1.50 | -1.30 | -1.60 |
EPS (Diluted) | -0.09 | -0.16 | -0.10 | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 | -0.25 | -0.27 | -0.31 | -0.34 | 0.29 | -0.57 | -0.48 | -0.83 | -1.11 | -1.19 | -1.17 | -1.50 | -1.30 | -1.60 |
EBITDA | -2.62M | -3.18M | -1.72M | -2M | -4.02M | n/a | -3.79M | -2.31M | 115.39K | 156.2K | -2.04M | -2.28M | -3.28M | -3.41M | -2.23M | -4.91M | -4.65M | -9.08M | -8.94M | -11.62M | -10.12M | -8.03M |
EBIT | n/a | -3.18M | -1.72M | -2M | -4.02M | -4.16M | -3.79M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -4.1M | -4.22M | -3.04M | -5.73M | -5.23M | -9.91M | -9.76M | -12.43M | -10.91M | -8.78M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 3 | 4.16M | n/a | n/a | 2.31M | 2.55M | 697.28K | 697.28K | 818.22K | 818.22K | 813.11K | 819.88K | 579.78K | 834.22K | 820.19K | 805.25K | 782.83K | 754.37K |
Add to Watchlist
Select watchlists to add or remove MRKR